Letter: Androgen role in erythroleukemia after treatment with alkylating agents.
D000328:Adult; D000477:Alkylating Agents / Q000008:administration & dosage*; D000728:Androgens / Q000009:adverse effects*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy; D002699:Chlorambucil / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D005474:Fluoxymesterone / Q000008:administration & dosage; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced* / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy; D009362:Neoplasm Metastasis; D013852:Thiotepa / Q000008:administration & dosage
D000477:Alkylating Agents; D000728:Androgens; D003561:Cytarabine; D002699:Chlorambucil; D013852:Thiotepa; D005474:Fluoxymesterone